Repurposing the yellow fever vaccine for intratumoral immunotherapy

par Aznar, Maria Angela, Molina, Carmen, Teijeira, Alvaro, Rodriguez, Inmaculada, Azpilikueta, Arantza, Garasa, Saray, Sanchez‐Paulete, Alfonso R, Cordeiro, Luna, Etxeberria, Iñaki, Alvarez, Maite, Rius‐Rocabert, Sergio, Nistal‐Villan, Estanislao, Berraondo, Pedro, Melero, Ignacio
Publié dans EMBO Mol Med (2019)

Cancer immunotherapy with immunomodulatory anti-CD137 and anti-PD-1 monoclonal antibodies requires Batf3-dependent dendritic cells

par Sánchez-Paulete, Alfonso R., Cueto, Francisco J., Martínez-López, María, Labiano, Sara, Morales-Kastresana, Aizea, Rodríguez-Ruiz, María E., Jure-Kunkel, Maria, Azpilikueta, Arantza, Aznar, M. Angela, Quetglas, José I., Sancho, David, Melero, Ignacio
Publié dans Cancer Discov (2015)

Hypoxia-induced soluble CD137 in malignant cells blocks CD137L-costimulation as an immune escape mechanism

par Labiano, Sara, Palazón, Asis, Bolaños, Elixabet, Azpilikueta, Arantza, Sánchez-Paulete, Alfonso R., Morales-Kastresana, Aizea, Quetglas, Jose I., Perez-Gracia, José L., Gúrpide, Alfonso, Rodriguez-Ruiz, Maria, Aznar, M. Angela, Jure-Kunkel, Maria, Berraondo, Pedro, Melero, Ignacio
Publié dans Oncoimmunology (2015)

Cellular cytotoxicity is a form of immunogenic cell death

par Minute, Luna, Teijeira, Alvaro, Sanchez-Paulete, Alfonso R, Ochoa, Maria C, Alvarez, Maite, Otano, Itziar, Etxeberrria, Iñaki, Bolaños, Elixabet, Azpilikueta, Arantza, Garasa, Saray, Casares, Noelia, Luis Perez Gracia, Jose, Rodriguez-Ruiz, Maria E, Berraondo, Pedro, Melero, Ignacio
Publié dans J Immunother Cancer (2020)

Functional expression of CD137 (4-1BB) on T helper follicular cells

par Alfaro, Carlos, Echeveste, Jose I, Rodriguez-Ruiz, Maria E, Solorzano, Jose L, Perez-Gracia, Jose L, Idoate, Miguel A, Lopez-Picazo, Jose M, Sanchez-Paulete, Alfonso R, Labiano, Sara, Rouzaut, Ana, Oñate, Carmen, Aznar, Angela, Lozano, Maria D, Melero, Ignacio
Publié dans Oncoimmunology (2015)

CD69 is a direct HIF-1α target gene in hypoxia as a mechanism enhancing expression on tumor-infiltrating T lymphocytes

par Labiano, Sara, Meléndez-Rodríguez, Florinda, Palazón, Asís, Teijeira, Álvaro, Garasa, Saray, Etxeberria, Iñaki, Aznar, M. Ángela, Sánchez-Paulete, Alfonso R., Azpilikueta, Arantza, Bolaños, Elixabet, Molina, Carmen, de la Fuente, Hortensia, Maiso, Patricia, Sánchez-Madrid, Francisco, de Landázuri, Manuel Ortiz, Aragonés, Julián, Melero, Ignacio
Publié dans Oncoimmunology (2017)

Short-Term Local Expression of a PD-L1 Blocking Antibody from a Self-Replicating RNA Vector Induces Potent Antitumor Responses

par Ballesteros-Briones, Maria Cristina, Martisova, Eva, Casales, Erkuden, Silva-Pilipich, Noelia, Buñuales, Maria, Galindo, Javier, Mancheño, Uxua, Gorraiz, Marta, Lasarte, Juan J., Kochan, Grazyna, Escors, David, Sanchez-Paulete, Alfonso R., Melero, Ignacio, Prieto, Jesus, Hernandez-Alcoceba, Ruben, Hervas-Stubbs, Sandra, Smerdou, Cristian
Publié dans Mol Ther (2019)

DNGR-1 limits Flt3L-mediated antitumor immunity by restraining tumor-infiltrating type I conventional dendritic cells

par Cueto, Francisco J, del Fresno, Carlos, Brandi, Paola, Combes, Alexis J., Hernández-García, Elena, Sánchez-Paulete, Alfonso R, Enamorado, Michel, Bromley, Christian P, Gomez, Manuel J, Conde-Garrosa, Ruth, Mañes, Santos, Zelenay, Santiago, Melero, Ignacio, Iborra, Salvador, Krummel, Matthew F., Sancho, David
Publié dans J Immunother Cancer (2021)